Synlogic (LTS:0A8U) YoY EBITDA Growth : 91.81% (As of Mar. 2025)

View and export this data going back to 2021. Start your Free Trial

What is Synlogic YoY EBITDA Growth?

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. Synlogic's YoY EBITDA Growth for the quarter that ended in Mar. 2025 was 91.81%.

Synlogic's EBITDA per Share for the three months ended in Mar. 2025 was $-0.07.

Synlogic YoY EBITDA Growth Historical Data

The historical data trend for Synlogic's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Synlogic YoY EBITDA Growth Chart

Synlogic Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

YoY EBITDA Growth

Get a 7-Day Free Trial

1.80

33.42

15.55

31.45

79.32

Synlogic Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
YoY EBITDA Growth	Get a 7-Day Free Trial															74.23	105.26	99.60	97.06	91.81

Synlogic YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

Synlogic's YoY EBITDA Growth for the fiscal year that ended in Dec. 2024 is calculated as:

	YoY EBITDA Growth (A: Dec. 2024 )
=	(EBITDA per Share (A: Dec. 2024 )	-	EBITDA per Share (A: Dec. 2023 ))	/	\| EBITDA per Share (A: Dec. 2023 ) \|
=	(-1.886	-	-9.12)	/	\| -9.12 \|
=	79.32 %

Synlogic's YoY EBITDA Growth for the quarter that ended in Mar. 2025 is calculated as:

	YoY EBITDA Growth (Q: Mar. 2025 )
=	(EBITDA per Share (Q: Mar. 2025 )	-	EBITDA per Share (Q: Mar. 2024 ))	/	\| EBITDA per Share (Q: Mar. 2024 )) \|
=	(-0.069	-	-0.842)	/	\| -0.842 \|
=	91.81 %

Synlogic YoY EBITDA Growth Related Terms

Thank you for viewing the detailed overview of Synlogic's YoY EBITDA Growth provided by GuruFocus.com. Please click on the following links to see related term pages.

Synlogic Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Synlogic Inc (LTS:0A8U) » Definitions » YoY EBITDA Growth

Comparable Companies

Traded in Other Exchanges

SYBX:USA

Address

PO Box 30, Winchester, MA, USA, 01890

Website

https://www.synlogictx.com

Synlogic Inc is a biopharmaceutical company focuses on rare metabolic disorders, with a lead program in phenylketonuria (PKU) and homocystinuria (HCU). The company's pipeline includes therapeutics for enteric hyperoxaluria, gout, and cystinuria. Using a proprietary approach, the company engineer GI-restricted, oral medicines from well-characterized probiotics. These drug candidates target specific biological pathways, leveraging Escherichia coli Nissle 1917 for consistency and safety. Engineered to be non-colonizing and reversible, the company offer oral administration, simplifying shipping and storage. The company operates in one segment-discovery and development of Synthetic Biotics-pioneering transformative treatments for serious diseases.

Synlogic Headlines

No Headlines